Article & News

Hepatitis B is a significant global health concern, affecting millions around the world due to its association with acute and chronic liver diseases, including hepatocellular

Drug discovery for metabolic diseases is fraught with challenges, demanding innovative approaches to improve efficacy and predictive value. The traditional reliance on animal models often

Metabolic diseases are complex conditions that disrupt the body’s ability to process essential nutrients, significantly affecting overall health. These disorders, including diabetes, obesity, fatty liver,

The study of HBV infections using mouse models has become increasingly crucial for developing treatments and understanding the disease’s complexities. Conducting research in this area

Hepatitis B virus (HBV) continues to pose significant public health challenges worldwide, making the need for effective drug development more crucial than ever. One of

In the realm of medical research, understanding diseases deeply is essential for developing effective treatments. Among various viral infections, hepatitis B virus (HBV) poses significant

The world of drug development for inflammatory and autoimmune diseases presents a maze of challenges. These complexities arise from the intricate nature of diseases such

The journey of drug discovery, particularly in the realm of inflammatory and autoimmune diseases, is often fraught with obstacles. In preclinical R&D practice, Jennio Biotech​

Autoimmune diseases represent a significant area of focus in biomedical research due to the complexity and variety of conditions affecting millions globally. As a partner

Deeply analyzing the complexities of liver cancer, particularly hepatocellular carcinoma (HCC), is imperative for developing innovative treatments. A pivotal aspect of this research involves the use